Todd Harris Tyra Biosciences, Inc. (TYRA) insider trading activity

Todd Harris is President and CEO of Tyra Biosciences, Inc.. Currently has a direct ownership of 1.36 Million shares of TYRA, which is worth approximately $14 Million. The most recent transaction as insider was on Jun 13, 2023, when has been sold 7,927 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $126,832. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.36M

0% 3M change

9.8% 12M change

Total Value Held $14 Million

Todd Harris Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2023	SELL Open market or private sale	$126,832 $16.0 p/Share	7,927 Reduced 0.46%	1,701,276 Common Stock
Jun 13 2023	BUY Exercise of conversion of derivative security	$17,835 $2.25 p/Share	7,927 Added 0.46%	1,709,203 Common Stock
Apr 03 2023	SELL Open market or private sale	$32,259 $16.13 p/Share	2,000 Reduced 0.12%	1,701,276 Common Stock
Apr 03 2023	BUY Exercise of conversion of derivative security	$4,500 $2.25 p/Share	2,000 Added 0.12%	1,703,276 Common Stock
Mar 31 2023	SELL Open market or private sale	$8,025 $16.05 p/Share	500 Reduced 0.03%	1,701,276 Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	$1,125 $2.25 p/Share	500 Added 0.03%	1,701,776 Common Stock
Mar 30 2023	SELL Open market or private sale	$38,560 $16.02 p/Share	2,407 Reduced 0.14%	1,701,276 Common Stock
Mar 30 2023	BUY Exercise of conversion of derivative security	$5,415 $2.25 p/Share	2,407 Added 0.14%	1,703,683 Common Stock
Mar 29 2023	SELL Open market or private sale	$22,975 $16.18 p/Share	1,420 Reduced 0.08%	1,701,276 Common Stock
Mar 29 2023	BUY Exercise of conversion of derivative security	$3,195 $2.25 p/Share	1,420 Added 0.08%	1,702,696 Common Stock
Mar 28 2023	SELL Open market or private sale	$44,464 $16.0 p/Share	2,779 Reduced 0.16%	1,701,276 Common Stock
Mar 28 2023	BUY Exercise of conversion of derivative security	$6,252 $2.25 p/Share	2,779 Added 0.16%	1,704,055 Common Stock
Mar 27 2023	SELL Open market or private sale	$47,408 $16.0 p/Share	2,963 Reduced 0.17%	1,701,276 Common Stock
Mar 27 2023	BUY Exercise of conversion of derivative security	$6,666 $2.25 p/Share	2,963 Added 0.17%	1,704,239 Common Stock
Mar 24 2023	SELL Open market or private sale	$2,720 $16.0 p/Share	170 Reduced 0.01%	1,701,276 Common Stock
Mar 24 2023	BUY Exercise of conversion of derivative security	$382 $2.25 p/Share	170 Added 0.01%	1,701,446 Common Stock
Mar 23 2023	SELL Open market or private sale	$44,800 $16.0 p/Share	2,800 Reduced 0.16%	1,701,276 Common Stock
Mar 23 2023	BUY Exercise of conversion of derivative security	$6,300 $2.25 p/Share	2,800 Added 0.16%	1,704,076 Common Stock
Mar 22 2023	SELL Open market or private sale	$64,688 $16.0 p/Share	4,043 Reduced 0.24%	1,701,276 Common Stock
Mar 22 2023	BUY Exercise of conversion of derivative security	$9,096 $2.25 p/Share	4,043 Added 0.24%	1,705,319 Common Stock
Mar 21 2023	SELL Open market or private sale	$198,288 $16.0 p/Share	12,393 Reduced 0.72%	1,701,276 Common Stock
Mar 21 2023	BUY Exercise of conversion of derivative security	$27,884 $2.25 p/Share	12,393 Added 0.72%	1,713,669 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	$11,896 $6.58 p/Share	1,808 Added 0.11%	1,701,276 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	$26,656 $8.53 p/Share	3,125 Added 0.18%	1,699,468 Common Stock
Sep 17 2021	BUY Conversion of derivative security	-	34,007 Added 1.97%	1,696,343 Common Stock

Todd Harris

President and CEO

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TYRA shares.

Notify only if

Value

Insider Trading

Get notified when an Tyra Biosciences, Inc. insider buys or sells TYRA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tyra Biosciences, Inc.

Track Activities on TYRA

Account